Sonic Healthcare reported a 1H19 result that was in line with consensus expectations. Moderate single digit earnings continue to flow through from Australia, US and Germany.
FY20 forecasts are for 3 – 4% EPS growth. We consider the stock slightly expensive and look to buy on a the next pullback.
You're not a member! Trial today
